Synthetic Biology Export Sanctions

Introduction

Synthetic Biology Export Sanctions refer to legal restrictions, licensing requirements and penalties imposed on the international export or transfer of synthetic biology materials, technologies and related information. These may include genetically modified organisms, microorganisms, toxins, genetic elements, biological research equipment, software and technical data.

Synthetic biology has important applications in medicine, agriculture, pharmaceutical production and industrial research. However, certain biological materials and technologies may have dual-use applications, meaning they can be used for peaceful scientific purposes as well as potentially harmful military or biological-weapons purposes. Export restrictions aim to prevent misuse, protect national security and fulfil international non-proliferation obligations.

India does not have a separate statute titled Synthetic Biology Export Sanctions. Its principal regulatory framework is based on strategic trade controls, the SCOMET list and legislation concerning weapons of mass destruction.

Legal and Regulatory Framework in India

1. Foreign Trade (Development and Regulation) Act, 1992: This Act empowers the Central Government to regulate exports. Chapter IVA provides important controls relating to specified goods, services and technologies connected with weapons of mass destruction.

2. SCOMET Framework: SCOMET means Special Chemicals, Organisms, Materials, Equipment and Technologies. Category 2 covers microorganisms and toxins, including bacteria, viruses, fungi, plant pathogens, genetic elements and genetically modified organisms. Related technology and software may also be controlled.

DGFT Content+1

3. Weapons of Mass Destruction Act, 2005: This legislation regulates activities involving weapons of mass destruction and their delivery systems. Section 13 addresses restrictions on the transfer of controlled technology, while Section 14 provides punishment for unauthorised exports. The Act also contains provisions concerning prohibited transfers and corporate liability.

India+1

4. Foreign Trade Policy, 2023: Chapter 10 establishes procedures for SCOMET exports. Paragraph 10.05 provides catch-all controls under which even non-listed items may be restricted where the exporter has been notified or knows, or has reason to believe, that the items may be diverted for prohibited weapons-related purposes.

DGFT Content+1

Important Case Laws

1. A.R. Sales Pvt. Ltd. v. Union of India, 2024:DHC:6034

The Delhi High Court examined restrictions imposed under SCOMET catch-all provisions on exports of civilian aircraft engines and parts. The Court held that speculative dual-use possibilities alone were insufficient to justify the restriction when technical evidence established civilian use and the goods did not fall within applicable controls. The judgment emphasises rational and evidence-based export regulation.

Indian Kanoon+1

2. Flyover Cargo Pvt. Ltd. v. Commissioner of Customs, Airport and General, New Delhi (CESTAT, 24 July 2024)

The Tribunal considered an attempted export of triethanolamine, a controlled SCOMET chemical, without the required authorisation. It treated the violation seriously, upheld a monetary penalty against the customs broker but set aside revocation of its licence and forfeiture of its security deposit. The decision highlights export compliance and proportionality of penalties.

Live Law+1

3. Vellore Citizens’ Welfare Forum v. Union of India (1996) 5 SCC 647

The Supreme Court recognised the precautionary principle and polluter-pays principle. These principles support preventive safeguards where biological exports may create serious environmental or public-health risks.

Major Legal Issues

Preventing unauthorised international transfer of controlled biological materials.

Controlling dual-use genetic technologies and biological research information.

Preventing biological-weapons proliferation.

Verifying foreign recipients and declared end uses.

Protecting legitimate scientific research and international cooperation.

Imposing appropriate penalties for unlawful exports.

Conclusion

Synthetic Biology Export Sanctions are an emerging aspect of biotechnology and strategic trade regulation. India's SCOMET framework, Foreign Trade (Development and Regulation) Act, 1992, WMD Act, 2005 and Foreign Trade Policy, 2023 provide the principal legal foundation. Future regulation should clarify the treatment of synthetic DNA sequences, digital biological design files, genetic engineering software and international research transfers. The objective should be to prevent misuse while allowing legitimate scientific and commercial cooperation.

Note: The cited cases concern general SCOMET export controls and environmental principles; none directly decides export sanctions involving synthetic biology.